Moving toward a better understanding of radioiodine action

The selective tropism for thyroid tissue makes radioiodine (RAI or I) a unique targeted therapy for both benign and malignant thyroid disorders. The efficacy of I is reliant upon uptake and retention of the isotope in thyrocytes to achieve doses of ionizing radiation sufficient to elicit clinically meaningful cytotoxicity. The processes that govern this can… CONTINUE READING